Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Micro Labs Limited, priced at $0.5592 per EA under NDC 42571027460. Its NADAC has been published 254 times since Oct 13, 2021.
FDA first approved this application on Aug 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 200 mg/1; mg/1
Manufacturer
Micro Labs LimitedNDC
42571027460
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA209929FDA Approved
8/11/2021
TE Code
AB
On Market Since
8/16/2021
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 254 times since Oct 13, 2021, and over the history we have for it it has declined 36.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5592 per EA |
|---|---|
| All-time high | $0.8919 (Nov 10, 2021) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.6897 |
| Average price | $0.7067 |
| Largest weekly change | +31.1% (Jun 19, 2024) |
| Weeks tracked | 254 |
| Tracking since | Oct 13, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ASPIRIN and Extended-Release DIPYRIDAMOLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Micro Labs Limited, is $0.5592 per EA (NDC 42571027460), effective Aug 19, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 36.2%. It has been tracked across 254 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Oct 13, 2021, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $0.8919 (Nov 10, 2021), with a median of $0.6897 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
No other NADAC-published product currently shares the active ingredient and strength of ASPIRIN-DIPYRIDAM ER 25-200 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 42571027460) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.